Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04708613 · ClinicalTrials.gov registry record

University of Pittsburgh Brain Health Initiative

A clinical trial of Traumatic Brain Injury, sponsored by David Okonkwo, MD, PhD.

Recruiting
Registry status
300
Enrollment target
1
Study location

NCT04708613: Recruiting study of Traumatic Brain Injury, sponsored by David Okonkwo, MD, PhD.

NCT04708613 is a study of Traumatic Brain Injury that is actively recruiting participants, run by David Okonkwo, MD, PhD. The registered enrollment target is 300 participants, roughly in line with the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04708613, a study of Traumatic Brain Injury, is actively recruiting participants, sponsored by David Okonkwo, MD, PhD.

RECRUITING
Registry status
300 participants
Enrollment target
1
Study location

Study Summary

This project will define the prevalence of brain health (i.e., normal cognitive, neuromotor, behavioral function) in living professional football retirees and group-matched controls through a comprehensive assessment of clinical, neuroimaging, and biomarker measures.

Primary Outcome

The diagnosis of cognitive impairment is based on the ADRC National Alzheimer's Coordinating Center (NACC) criteria for mild cognitive impairment. This criteria is adjudicated following a comprehensive neuropsychological exam, and includes: (1) Self- or informant-reported cognitive complaint, (2) Objective cognitive impairment, (3) Preserved independence in functional abilities, and (4) No dementia.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Cognitive/Neuropsychological Testing
  • DIAGNOSTIC_TEST Vestibular/Ocular-Motor Testing
  • DIAGNOSTIC_TEST Sleep Evaluation
  • DIAGNOSTIC_TEST MRI, High-Resolution
  • DIAGNOSTIC_TEST Health & Physical Exam

Study Locations (1)

Pennsylvania

  • University of Pittsburgh Department of Neurosurgery - Pittsburgh

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2019-11-18
Est. Completion 2026-12
David Okonkwo, MD, PhD

1 total trials

What NCT04708613 shows while recruiting

NCT04708613 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target.

The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 5 interventions - of which Cognitive/Neuropsychological Testing is the first listed.

NCT04708613 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04708613 about?

NCT04708613 is a clinical study titled "University of Pittsburgh Brain Health Initiative". This project will define the prevalence of brain health (i.e., normal cognitive, neuromotor, behavioral function) in living professional football retirees and group-matched controls through a comprehensive assessment of clinical, neuroimaging, and biomarker measures.

What is the current status of trial NCT04708613?

This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2019-11-18. Estimated completion is 2026-12.

What conditions does trial NCT04708613 study?

This clinical trial studies the following conditions: Traumatic Brain Injury.

What interventions are being tested in trial NCT04708613?

The interventions under investigation include: Cognitive/Neuropsychological Testing (DIAGNOSTIC_TEST), Vestibular/Ocular-Motor Testing (DIAGNOSTIC_TEST), Sleep Evaluation (DIAGNOSTIC_TEST), MRI, High-Resolution (DIAGNOSTIC_TEST), Health & Physical Exam (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04708613?

This trial is sponsored by David Okonkwo, MD, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04708613 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04708613's enrollment target sits among peer trials

300 20th of 171 higher than 146 of 171 other Traumatic Brain Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04708613, the US trial registry maintained by the National Library of Medicine. NCT04708613 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.